Here we addressed whether NK cells have the potential to control chronic myeloid leukemia (CML) arising based on the transplantation of BCR-ABL1 oncogene expressing primary bone marrow precursor cells into lethally irradiated recipient mice. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.